Skip to main content
Fig. 6 | BMC Cardiovascular Disorders

Fig. 6

From: Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease

Fig. 6

Comparison of the risk of NACE after 18 months among sustained PPI, intermittent PPI and non-PPI users. a Proportion of NACE after 18 months in sustained PPI, intermittent PPI and non-PPI users. b Kaplan–Meier survival curves representing the estimated cumulative incidence of NACE after 18 months in sustained PPI, intermittent PPI and non-PPI users. GI, gastrointestinal; MI, myocardial infarction; NACE, net adverse clinical events; PPI, proton pump inhibitor

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us